Skip to main content
SpringerLink
Log in

Serum-derived bovine immunoglobulin/protein isolate should be considered in patients with HIV gut barrier dysfunction

  • Correspondence
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Assimakopoulos SF, Dimitropoulou D, Marangos M, Gogos CA. Intestinal barrier dysfunction in HIV infection: pathophysiology, clinical implications and potential therapies. Infection. 2014;42:951–9.

    Article  CAS  PubMed  Google Scholar 

  2. Hunt PW, Sinclair E, Rodriguez B, et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J Infect Dis. 2014;210(8):1228–38.

    Article  CAS  PubMed  Google Scholar 

  3. Asmuth DA, Ma Z-M, Albanese A, et al. Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy. AIDS. 2013;27(14):2207–17.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Petschow BW, Burnett B, Shaw AL, Weaver EM, Klein GL. Serum-derived bovine immunoglobulin/protein isolate: postulated mechanism of action for management of enteropathy. Clin Exp Gastroenterol. 2014;7:181–90.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Torrallardona D. Spray dried animal plasma as an alternative to antibiotics in weanling pigs––a review. Asian–Aust J Anim Sci. 2010;23:131–48.

    CAS  Google Scholar 

Download references

Conflict of interest

MSG is a speaker and BPB is an employee of Entera Health, Inc.

Author information

Authors and Affiliations

  1. University of Tennessee Health Science Center, Memphis, TN, USA

    M. S. Gelfand

  2. Division of Infectious Diseases, Methodist University Hospital of Memphis, Memphis, TN, USA

    M. S. Gelfand

  3. Medical Affairs, Entera Health, Inc., Cary, NC, USA

    B. P. Burnett

Authors
  1. M. S. Gelfand
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. P. Burnett
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. P. Burnett.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gelfand, M.S., Burnett, B.P. Serum-derived bovine immunoglobulin/protein isolate should be considered in patients with HIV gut barrier dysfunction. Infection 43, 253–254 (2015). https://doi.org/10.1007/s15010-015-0732-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-015-0732-7

Keywords

Search

Navigation